2 completed, 1 unknown. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Azacitadine: new trials by email Literature Review of Azacitadine trials Research Report on Azacitadine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patients pembrolizumab, Azacitadine - Acute Myeloid Leukemia | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 67 | 2016-07-01 | 2023-03-09 |
| Study Evaluating Venetoclax in Subjects With Hematological Malignancies azacitadine, venetoclax, rituximab / IDEC-C2B8 - Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM) | Phase 1 / Phase 2 | Completed | AbbVie | 38 | 2014-09-22 | 2021-08-02 |
| Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS Vidaza and Valproic Acid - Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS | Phase 2 | Unknown | Patrick Stiff | 50 | 2012-01-01 | 2021-04-26 |
Leukemia, Myeloid, Acute (3) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphatic Diseases (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1)
AbbVie (1) · Patrick Stiff (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (2) · Japan (1)
Ivana Gojo, MD (1) · Patrick Stiff, MD (1)